Citation Impact
Citing Papers
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
2012
The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence
2020 Standout
Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models
2007
Acute Biological Effects of Simulating the Whole-Body Radiation Dose Distribution from a Solar Particle Event Using a Porcine Model
2011 StandoutNobel
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Phase II Pilot Study of Bevacizumab in Combination with Temozolomide and Regional Radiation Therapy for Up-Front Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Interim Analysis of Safety and Tolerability
2008
Pancreatic cancer
2004 Standout
Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy
2016
Curcumin Modulates the Radiosensitivity of Colorectal Cancer Cells by Suppressing Constitutive and Inducible NF-κB Activity
2009
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
2011
Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
2013
Management of borderline and locally advanced pancreatic cancer: Where do we stand?
2014
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Pancreatic cancer
2020 Standout
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
2014
Critical role of TRPC6 channels in VEGF-mediated angiogenesis
2009
Advanced pancreatic carcinoma: current treatment and future challenges
2010
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Pancreatic cancer
2016 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Definition and classification of cancer cachexia: an international consensus
2011 Standout
Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis
2017
Soft-Tissue Sarcomas in Adults
2005 Standout
Colorectal cancer
2013 Standout
Engineering the perfect (bacterial) cancer therapy
2010 Standout
The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
2013
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
2020
Polyoxometalates: Building Blocks for Functional Nanoscale Systems
2010 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Pancreatic Adenocarcinoma
2014 Standout
Colorectal cancer
2019 Standout
Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
2015
Radiation Therapy–Related Toxicity (Including Pneumonitis and Fibrosis)
2009
British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults
2011
Pancreatic cancer
2002
Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
2012
Nasopharyngeal carcinoma
2015 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma
2018
Interpretative strategies for lung function tests
2005 Standout
Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy
2012
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Malignant Gliomas in Adults
2008 Standout
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
2006
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Gastric cancer
2020 Standout
Pancreatic Cancer
2010 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Weight loss in patients with advanced cancer: effects, causes, and potential management
2008
Percutaneous Irreversible Electroporation for the Treatment of Colorectal Cancer Liver Metastases with a Proposal for a New Response Evaluation System
2014
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
2008
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients
2010
Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures
2012
Intestinal mucositis: mechanisms and management
2007
Pancreatic cancer
2011 Standout
Central Airway Obstruction
2004
Health functionality of apigenin: A review
2016
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
The Therapeutic Potential of Apigenin
2019 Standout
Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid Cancers
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
What Is the Role for the Circumferential Margin in the Modern Treatment of Rectal Cancer?
2008
Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review
2009
Cancer treatment and survivorship statistics, 2016
2016 Standout
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
2016
Cancer treatment and survivorship statistics, 2019
2019 Standout
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
2003
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Management of Bleeding from Unresectable Gastric Cancer
2019
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer
2017 Standout
American Cancer Society Colorectal Cancer Survivorship Care Guidelines
2015
Efficacy of the Oral Fluorouracil Pro-drug Capecitabine in Cancer Treatment: a Review
2008
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
2008 Standout
Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to γ-Radiation by Targeting Nuclear Factor-κB–Regulated Gene Products
2008
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology
2005
Works of Marc E. Delclos being referenced
Clinical benefit of palliative radiation therapy in advanced gastric cancer
2008
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
2002
Conformal Radiotherapy of the Dominant Liver Metastasis
2006
Limitations of conventional doses of chemoradiation for unresectable biliary cancer
2002
Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
2006
Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer
2006
Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated With Preoperative Chemoradiation Therapy for Rectal Cancer
2009
High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year M. D. Anderson Cancer Center experience
2000
Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center
2000
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis
2006
Long‐term quality of life after radiotherapy for the treatment of anal cancer
2009
Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy
2007
Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation
2006
Brachytherapy for Locally Recurrent Soft-Tissue Sarcoma
2002
Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients
2004
Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience
2012
Response to preoperative chemoradiation increases the use of sphincter‐preserving surgery in patients with locally advanced low rectal carcinoma
2003
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer
2015
Metformin use and improved response to therapy in rectal cancer
2013
Utility of the of the M. D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation (CRT) in patients with gastrointestinal malignancies
2007
Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer
2006